Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Treatment of sickle cell disease (SCD) is hampered by incomplete understanding of pathways linking hemolysis to vaso-occlusion. We investigated these pathways in transgenic sickle mice. Infusion of hemoglobin or heme triggered vaso-occlusion in sickle, but not normal, mice. Methemoglobin, but not heme-stabilized cyanomethemoglobin, induced vaso-occlusion, indicating heme liberation is necessary. In corroboration, hemoglobin-induced vaso-occlusion was blocked by the methemoglobin reducing agent methylene blue, haptoglobin, or the heme-binding protein hemopexin. Untreated HbSS mice, but not HbAA mice, exhibited ∼10% vaso-occlusion in steady state that was inhibited by haptoglobin or hemopexin infusion. Antibody blockade of adhesion molecules P-selectin, von Willebrand factor (VWF), E-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, platelet endothelial cell (EC) adhesion molecule 1, α4β1, or αVβ3 integrin prevented vaso-occlusion. Heme rapidly (5 minutes) mobilized Weibel-Palade body (WPB) P-selectin and VWF onto EC and vessel wall surfaces and activated EC nuclear factor κB (NF-κB). This was mediated by TLR4 as TAK-242 blocked WPB degranulation, NF-κB activation, vaso-occlusion, leukocyte rolling/adhesion, and heme lethality. TLR4(-/-) mice transplanted with TLR4(+/+) sickle bone marrow exhibited no heme-induced vaso-occlusion. The TLR4 agonist lipopolysaccharide (LPS) activated ECs and triggered vaso-occlusion that was inhibited by TAK-242, linking hemolysis- and infection-induced vaso-occlusive crises to TLR4 signaling. Heme and LPS failed to activate VWF and NF-κB in TLR4(-/-) ECs. Anti-LPS immunoglobulin G blocked LPS-induced, but not heme-induced, vaso-occlusion, illustrating LPS-independent TLR4 signaling by heme. Inhibition of protein kinase C, NADPH oxidase, or antioxidant treatment blocked heme-mediated stasis, WPB degranulation, and oxidant production. We conclude that intravascular hemolysis in SCD releases heme that activates endothelial TLR4 signaling leading to WPB degranulation, NF-κB activation, and vaso-occlusion.

[1]  J. L. Ding,et al.  Extracellular haemoglobin upregulates and binds to tissue factor on macrophages: Implications for coagulation and oxidative stress , 2013, Thrombosis and Haemostasis.

[2]  S. Ofori-Acquah,et al.  Extracellular hemin crisis triggers acute chest syndrome in sickle mice. , 2013, The Journal of clinical investigation.

[3]  G. Vercellotti,et al.  Vasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses , 2013, ISRN oxidative medicine.

[4]  L. Silengo,et al.  Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases , 2013, Circulation.

[5]  N. Mohandas,et al.  Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease. , 2013, Blood.

[6]  P. Buehler,et al.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. , 2013, Blood.

[7]  Zhou Zhou,et al.  Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease. , 2012, Current vascular pharmacology.

[8]  M. Gladwin,et al.  Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO‐1 induction , 2011, British journal of haematology.

[9]  J. Voorberg,et al.  Functional architecture of Weibel-Palade bodies. , 2011, Blood.

[10]  P. D. de Groot,et al.  The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. , 2011, Blood.

[11]  M. Gladwin,et al.  Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. , 2011, JAMA.

[12]  N. Tsuchimori,et al.  TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules , 2011, Molecular Pharmacology.

[13]  N. Sepúlveda,et al.  A Central Role for Free Heme in the Pathogenesis of Severe Sepsis , 2010, Science Translational Medicine.

[14]  D. Simone,et al.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. , 2010, Blood.

[15]  B. Pace,et al.  The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. , 2010, Blood.

[16]  N. Morello,et al.  Heme scavenging and the other facets of hemopexin. , 2010, Antioxidants & redox signaling.

[17]  G. Vercellotti,et al.  Heme degradation and vascular injury. , 2010, Antioxidants & redox signaling.

[18]  S. Doré,et al.  Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  K. Ataga,et al.  Fibronectin bridges monocytes and reticulocytes via integrin α4β1 , 2008, British journal of haematology.

[20]  M. Telen.  Faculty Opinions recommendation of Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1. , 2008 .

[21]  Tatiana P. Dutra,et al.  Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.

[22]  R. Figueiredo,et al.  Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.

[23]  R. Carmody,et al.  Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. , 2007, Cellular & molecular immunology.

[24]  T. Townes,et al.  Correction of sickle cell disease by homologous recombination in embryonic stem cells. , 2006, Blood.

[25]  N. Mohandas,et al.  Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. , 2006, American journal of physiology. Cell physiology.

[26]  L. Otterbein,et al.  Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. , 2006, The Journal of clinical investigation.

[27]  S. Ballas,et al.  Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia , 2006, Transfusion.

[28]  A. Karsan,et al.  Lipopolysaccharide signaling in endothelial cells , 2006, Laboratory Investigation.

[29]  M. Gladwin,et al.  Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. , 2005, The Journal of clinical investigation.

[30]  P. Højrup,et al.  Identification of the receptor scavenging hemopexin-heme complexes. , 2005, Blood.

[31]  N. Huy,et al.  An improved colorimetric method for quantitation of heme using tetramethylbenzidine as substrate. , 2005, Analytical biochemistry.

[32]  A. Zannettino,et al.  Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor , 2005, Journal of cellular physiology.

[33]  D. Granger,et al.  Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  John C Bischof,et al.  Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. , 2005, American journal of physiology. Heart and circulatory physiology.

[35]  T. Mayadas,et al.  The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. , 2004, Blood.

[36]  H. Park,et al.  Cutting Edge: Direct Interaction of TLR4 with NAD(P)H Oxidase 4 Isozyme Is Essential for Lipopolysaccharide-Induced Production of Reactive Oxygen Species and Activation of NF-κB1 , 2004, The Journal of Immunology.

[37]  M. Gladwin,et al.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.

[38]  D. Granger,et al.  Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice. , 2004, American journal of physiology. Heart and circulatory physiology.

[39]  Carl G. Figdor,et al.  Different Faces of the Heme-Heme Oxygenase System in Inflammation , 2003, Pharmacological Reviews.

[40]  J. Bischof,et al.  Transgenic sickle mice have vascular inflammation. , 2003, Blood.

[41]  M. Gladwin,et al.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. , 2002 .

[42]  A. Meneshian,et al.  Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation. , 2002, American journal of physiology. Heart and circulatory physiology.

[43]  P. Oliveira,et al.  Neutrophil activation by heme: implications for inflammatory processes. , 2002, Blood.

[44]  B. Coller,et al.  Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[46]  G. Vercellotti,et al.  Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. , 2000, Blood.

[47]  R. Hebbel,et al.  Amendment history : Erratum ( September 2000 ) Hypoxia / reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice , 2018 .

[48]  J. Eaton,et al.  Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Alam,et al.  Identification of the histidine residues of hemopexin that coordinate with heme-iron and of a receptor-binding region. , 1993, The Journal of biological chemistry.

[50]  R. Nagel,et al.  High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  W. T. Morgan,et al.  Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Moake,et al.  Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. , 1987, The Journal of clinical investigation.

[53]  A. Smith,et al.  Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. , 1979, The Biochemical journal.

[54]  U. Muller-eberhard,et al.  Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. , 1968, Blood.

[55]  H. Bunn,et al.  Exchange of heme among hemoglobins and between hemoglobin and albumin. , 1968, The Journal of biological chemistry.

[56]  W B Wendel,et al.  THE CONTROL OF METHEMOGLOBINEMIA WITH METHYLENE BLUE. , 1939, The Journal of clinical investigation.